"10.1371_journal.pone.0134240","plos one","2015-07-31T00:00:00Z","Makoto Kondo; Masayuki Yamato; Ryo Takagi; Hideo Namiki; Teruo Okano","Institute of Advanced Biomedical Engineering and Science, Tokyo Womenâ€™s Medical University, TWIns, 8â€1 Kawada-cho, Shinjuku-ku, Tokyo, 162â€8666, Japan; Graduate School of Advanced Science and Engineering, Waseda University, 2â€2 Wakamatsu-cho, Shinjuku-ku, Tokyo, 162â€8480, Japan","Conceived and designed the experiments: MK MY HN TO. Performed the experiments: MK. Analyzed the data: MK MY RT. Contributed reagents/materials/analysis tools: MY HN TO. Wrote the paper: MK MY.","Teruo Okano is the founder and director of the board of CellSeed, Inc., which licenses technologies and patents from Tokyo Womenâ€™s Medical University. Teruo Okano and Masayuki Yamato are stakeholders in CellSeed, Inc. Tokyo Womenâ€™s Medical University receives research funds from CellSeed, Inc. Teruo Okano, Masayuki Yamato, and Makoto Kondo are named as inventors on a patent relevant to this research. The authors confirm the conflicts of interest do not alter their adherence to all PLOS ONE policies on sharing data and materials.","2015","07","Makoto Kondo","MK",5,TRUE,4,1,3,2,TRUE,TRUE,FALSE,0,NA,FALSE
